Logo image of OFIX

ORTHOFIX MEDICAL INC (OFIX) Stock Fundamental Analysis

NASDAQ:OFIX - Nasdaq - US68752M1080 - Common Stock - Currency: USD

11  -0.16 (-1.43%)

After market: 11 0 (0%)

Fundamental Rating

3

Taking everything into account, OFIX scores 3 out of 10 in our fundamental rating. OFIX was compared to 188 industry peers in the Health Care Equipment & Supplies industry. OFIX has a bad profitability rating. Also its financial health evaluation is rather negative. OFIX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OFIX had positive earnings in the past year.
OFIX had a positive operating cash flow in the past year.
OFIX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OFIX reported negative operating cash flow in multiple years.
OFIX Yearly Net Income VS EBIT VS OCF VS FCFOFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

OFIX has a Return On Assets (-17.38%) which is comparable to the rest of the industry.
OFIX has a Return On Equity of -31.22%. This is comparable to the rest of the industry: OFIX outperforms 54.79% of its industry peers.
Industry RankSector Rank
ROA -17.38%
ROE -31.22%
ROIC N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
OFIX Yearly ROA, ROE, ROICOFIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

OFIX has a better Gross Margin (67.15%) than 72.87% of its industry peers.
In the last couple of years the Gross Margin of OFIX has declined.
OFIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
OFIX Yearly Profit, Operating, Gross MarginsOFIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OFIX has been increased compared to 1 year ago.
OFIX has more shares outstanding than it did 5 years ago.
OFIX has a worse debt/assets ratio than last year.
OFIX Yearly Shares OutstandingOFIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OFIX Yearly Total Debt VS Total AssetsOFIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that OFIX is in the distress zone and has some risk of bankruptcy.
OFIX has a Altman-Z score (1.10) which is comparable to the rest of the industry.
OFIX has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
OFIX has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACCN/A
WACC8.2%
OFIX Yearly LT Debt VS Equity VS FCFOFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.71 indicates that OFIX has no problem at all paying its short term obligations.
OFIX has a Current ratio (2.71) which is in line with its industry peers.
A Quick Ratio of 1.50 indicates that OFIX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.50, OFIX is in line with its industry, outperforming 42.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 1.5
OFIX Yearly Current Assets VS Current LiabilitesOFIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 400.00% over the past year.
OFIX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -63.14% yearly.
OFIX shows a small growth in Revenue. In the last year, the Revenue has grown by 5.86%.
Measured over the past years, OFIX shows a quite strong growth in Revenue. The Revenue has been growing by 11.69% on average per year.
EPS 1Y (TTM)400%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%38.46%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%2.67%

3.2 Future

OFIX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 330.10% yearly.
The Revenue is expected to grow by 5.39% on average over the next years.
EPS Next Y1583%
EPS Next 2Y820.11%
EPS Next 3Y330.1%
EPS Next 5YN/A
Revenue Next Year2.35%
Revenue Next 2Y4.2%
Revenue Next 3Y5.39%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OFIX Yearly Revenue VS EstimatesOFIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
OFIX Yearly EPS VS EstimatesOFIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

OFIX is valuated quite expensively with a Price/Earnings ratio of 183.33.
Compared to the rest of the industry, the Price/Earnings ratio of OFIX indicates a somewhat cheap valuation: OFIX is cheaper than 63.83% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of OFIX to the average of the S&P500 Index (26.31), we can say OFIX is valued expensively.
Based on the Price/Forward Earnings ratio of 12.99, the valuation of OFIX can be described as correct.
Based on the Price/Forward Earnings ratio, OFIX is valued cheaply inside the industry as 85.64% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.13. OFIX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 183.33
Fwd PE 12.99
OFIX Price Earnings VS Forward Price EarningsOFIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OFIX Per share dataOFIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

OFIX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OFIX's earnings are expected to grow with 330.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y820.11%
EPS Next 3Y330.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OFIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORTHOFIX MEDICAL INC

NASDAQ:OFIX (6/13/2025, 8:00:02 PM)

After market: 11 0 (0%)

11

-0.16 (-1.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-04 2025-08-04/amc
Inst Owners88.16%
Inst Owner Change8.46%
Ins Owners1.33%
Ins Owner Change4.86%
Market Cap430.98M
Analysts82
Price Target24.89 (126.27%)
Short Float %2.61%
Short Ratio2.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)104.9%
Min EPS beat(2)70.59%
Max EPS beat(2)139.22%
EPS beat(4)4
Avg EPS beat(4)120.23%
Min EPS beat(4)70.59%
Max EPS beat(4)145.75%
EPS beat(8)8
Avg EPS beat(8)113.18%
EPS beat(12)11
Avg EPS beat(12)87.85%
EPS beat(16)13
Avg EPS beat(16)69.85%
Revenue beat(2)0
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-0.65%
Max Revenue beat(2)-0.61%
Revenue beat(4)0
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.26%
Revenue beat(8)2
Avg Revenue beat(8)-0.82%
Revenue beat(12)3
Avg Revenue beat(12)-2.09%
Revenue beat(16)4
Avg Revenue beat(16)-1.23%
PT rev (1m)0.41%
PT rev (3m)0.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200.3%
EPS NY rev (1m)15.12%
EPS NY rev (3m)650%
Revenue NQ rev (1m)-2.84%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-1.31%
Valuation
Industry RankSector Rank
PE 183.33
Fwd PE 12.99
P/S 0.54
P/FCF N/A
P/OCF 16.58
P/B 0.94
P/tB 2.37
EV/EBITDA N/A
EPS(TTM)0.06
EY0.55%
EPS(NY)0.85
Fwd EY7.7%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.66
OCFY6.03%
SpS20.53
BVpS11.7
TBVpS4.65
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.38%
ROE -31.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.15%
FCFM N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
F-Score5
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.67%
Cap/Sales 3.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.71
Quick Ratio 1.5
Altman-Z 1.1
F-Score5
WACC8.2%
ROIC/WACCN/A
Cap/Depr(3y)86.5%
Cap/Depr(5y)81.89%
Cap/Sales(3y)6%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%38.46%
EPS Next Y1583%
EPS Next 2Y820.11%
EPS Next 3Y330.1%
EPS Next 5YN/A
Revenue 1Y (TTM)5.86%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%2.67%
Revenue Next Year2.35%
Revenue Next 2Y4.2%
Revenue Next 3Y5.39%
Revenue Next 5YN/A
EBIT growth 1Y4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.12%
EBIT Next 3Y53.95%
EBIT Next 5YN/A
FCF growth 1Y92.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y168.77%
OCF growth 3Y11.71%
OCF growth 5Y-4.22%